Evidence map›Paper›PMID 30449244›Full record

ArticleGut microbes2019

Immune/microbial interface perturbation in human IgA deficiency.

Delphine Sterlin, Claire Fieschi, Marion Malphettes, Martin Larsen, Guy Gorochov, Jehane Fadlallah

Abstract read
In one paragraph

Article in Gut microbes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Serum antibody titers againstFrontiers in oral health · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Gut Microbiota-Host Interactions in Inborn Errors of Immunity.International journal of molecular sciences · 2021
    Review
  9. Clinical implications of nicotine as an antimicrobial agent and immune modulator.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2020
    Review
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Delphine Sterlina Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses-Paris (CIMI-Paris), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié-Salpêtrière, , Département d'Immunologie , Paris , France.
Claire Fieschib Department of Clinical Immunology , Université Paris Diderot Paris 7 , Paris , France.
Marion Malphettesb Department of Clinical Immunology , Université Paris Diderot Paris 7 , Paris , France.
Martin Larsena Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses-Paris (CIMI-Paris), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié-Salpêtrière, , Département d'Immunologie , Paris , France.
Guy Gorochova Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses-Paris (CIMI-Paris), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié-Salpêtrière, , Département d'Immunologie , Paris , France.
Jehane Fadlallaha Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses-Paris (CIMI-Paris), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié-Salpêtrière, , Département d'Immunologie , Paris , France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a recently published article we report the metagenomic analysis of human gut microbiomes evolved in the absence of immunoglobulin A (IgA). We show that human IgA deficiency is not associated with massive quantitative perturbations of gut microbial ecology. While our study underlines a rather expected pathobiont expansion, we at the same time highlight a less expected depletion in some typically beneficial symbionts. We also show that IgM partially supply IgA deficiency, explaining the relatively mild clinical phenotype associated with the early steps of this condition. Microbiome studies in patients should consider potential issues such as cohort size, human genetic polymorphism and treatments. In this commentary, we discuss how such issues were taken into account in our own study.

Indexed as

BacteriaBiodiversityCommon Variable ImmunodeficiencyGastrointestinal MicrobiomeHumansIgA DeficiencyImmunoglobulin AImmunoglobulin MImmunoglobulin AImmunoglobulin MCVIDgut microbiotaIgA deficiencyIgMmicrobiome

Identifiers

PMID30449244
PMCPMC6546332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.